DE69227899D1 - Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen - Google Patents
Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionenInfo
- Publication number
- DE69227899D1 DE69227899D1 DE69227899T DE69227899T DE69227899D1 DE 69227899 D1 DE69227899 D1 DE 69227899D1 DE 69227899 T DE69227899 T DE 69227899T DE 69227899 T DE69227899 T DE 69227899T DE 69227899 D1 DE69227899 D1 DE 69227899D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- benzimidazole
- worm
- treating
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 241000243190 Microsporidia Species 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919106278A GB9106278D0 (en) | 1991-03-25 | 1991-03-25 | Method of treatment |
| PCT/GB1992/000522 WO1992016208A1 (en) | 1991-03-25 | 1992-03-23 | Use of benzimidazole anthelmintic in the treatment of microsporidial infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69227899D1 true DE69227899D1 (de) | 1999-01-28 |
| DE69227899T2 DE69227899T2 (de) | 1999-07-01 |
Family
ID=10692149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69227899T Expired - Fee Related DE69227899T2 (de) | 1991-03-25 | 1992-03-23 | Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5432187A (de) |
| EP (1) | EP0576506B1 (de) |
| JP (1) | JPH06505733A (de) |
| KR (1) | KR100227125B1 (de) |
| AT (1) | ATE174507T1 (de) |
| AU (1) | AU657317B2 (de) |
| CA (1) | CA2103787A1 (de) |
| DE (1) | DE69227899T2 (de) |
| DK (1) | DK0576506T3 (de) |
| ES (1) | ES2125890T3 (de) |
| GB (1) | GB9106278D0 (de) |
| GR (1) | GR3029357T3 (de) |
| IE (1) | IE920930A1 (de) |
| MX (1) | MX9201288A (de) |
| PT (1) | PT100284B (de) |
| WO (1) | WO1992016208A1 (de) |
| ZA (1) | ZA922102B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861142A (en) * | 1996-03-25 | 1999-01-19 | Schick; Mary Pichler | Method for promoting hair, nail, and skin keratinization |
| US6280768B1 (en) * | 1996-07-03 | 2001-08-28 | Prm Pharmaceuticals, Inc. | Berberine alkaloids as a treatment for chronic protozoally induced diarrhea |
| US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4761M (de) * | 1965-08-05 | 1967-01-16 | ||
| US3915986A (en) * | 1974-06-19 | 1975-10-28 | Smithkline Corp | Methyl 5-propylthio-2-benzimidazolecarbamate |
-
1991
- 1991-03-25 GB GB919106278A patent/GB9106278D0/en active Pending
-
1992
- 1992-03-10 US US08/117,160 patent/US5432187A/en not_active Expired - Fee Related
- 1992-03-23 WO PCT/GB1992/000522 patent/WO1992016208A1/en active IP Right Grant
- 1992-03-23 CA CA002103787A patent/CA2103787A1/en not_active Abandoned
- 1992-03-23 JP JP4506405A patent/JPH06505733A/ja active Pending
- 1992-03-23 ZA ZA922102A patent/ZA922102B/xx unknown
- 1992-03-23 DE DE69227899T patent/DE69227899T2/de not_active Expired - Fee Related
- 1992-03-23 AU AU15500/92A patent/AU657317B2/en not_active Ceased
- 1992-03-23 DK DK92906755T patent/DK0576506T3/da active
- 1992-03-23 KR KR1019930702876A patent/KR100227125B1/ko not_active Expired - Fee Related
- 1992-03-23 AT AT92906755T patent/ATE174507T1/de not_active IP Right Cessation
- 1992-03-23 ES ES92906755T patent/ES2125890T3/es not_active Expired - Lifetime
- 1992-03-23 MX MX9201288A patent/MX9201288A/es unknown
- 1992-03-23 EP EP92906755A patent/EP0576506B1/de not_active Expired - Lifetime
- 1992-03-24 PT PT100284A patent/PT100284B/pt not_active IP Right Cessation
- 1992-03-24 IE IE093092A patent/IE920930A1/en not_active IP Right Cessation
-
1999
- 1999-02-10 GR GR990400444T patent/GR3029357T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE174507T1 (de) | 1999-01-15 |
| PT100284B (pt) | 1999-08-31 |
| MX9201288A (es) | 1992-10-01 |
| AU1550092A (en) | 1992-10-21 |
| AU657317B2 (en) | 1995-03-09 |
| DE69227899T2 (de) | 1999-07-01 |
| US5432187A (en) | 1995-07-11 |
| EP0576506A1 (de) | 1994-01-05 |
| WO1992016208A1 (en) | 1992-10-01 |
| PT100284A (pt) | 1993-06-30 |
| GB9106278D0 (en) | 1991-05-08 |
| ES2125890T3 (es) | 1999-03-16 |
| ZA922102B (en) | 1993-09-23 |
| CA2103787A1 (en) | 1992-09-26 |
| KR100227125B1 (ko) | 1999-10-15 |
| DK0576506T3 (da) | 1999-08-23 |
| EP0576506B1 (de) | 1998-12-16 |
| GR3029357T3 (en) | 1999-05-28 |
| HK1012238A1 (en) | 1999-07-30 |
| JPH06505733A (ja) | 1994-06-30 |
| IE920930A1 (en) | 1992-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| DE69330403D1 (de) | Behandlung und prophylaxe von durch parasiten oder bakterien verursachten erkrankungen | |
| DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| DE69323183D1 (de) | Weitere indolderivate mit antiviraler wirkung | |
| DE69019533D1 (de) | Behandlung von hiv-infizierungen und nützliche verbindungen dafür. | |
| ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
| DE69130497D1 (de) | Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis | |
| DE69333014D1 (de) | Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks | |
| DE69227899D1 (de) | Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| DE69516110D1 (de) | Verwendung von riluzol zur behandlung mitochondrialer erkrankungen | |
| DE69400704D1 (de) | N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten | |
| ATE143946T1 (de) | N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten | |
| DE69626301D1 (de) | Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen | |
| DE69511453D1 (de) | Verwendung einer Kombination von Antineoplastonen zur Herstellung eines Arzneimittels zur Behandlung der Neurofibromatose | |
| DE59006159D1 (de) | Verwendung von macrolactonen als antiallergica. | |
| ATE24834T1 (de) | Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden. | |
| DE69421705D1 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen | |
| ATE122674T1 (de) | Ethanoladdukte von 6-sulfonylsubstituierten 3- hydroxychromanen und ihre verwendung als inhalationsmittel bei krankheiten. | |
| ATE255417T1 (de) | Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen | |
| DE59504374D1 (de) | Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen | |
| DE69210737D1 (de) | Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen | |
| ATE335494T1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen | |
| DE69329252D1 (de) | Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |